A breakthrough in pinpointing protective mechanisms in Multiple Sclerosis

Alexandre Prat

December 1st, 2011 – In an article published today in the prestigious journal Science, a team of researchers led by Dr Alexander Prat and postgraduate fellow Jorge Alvarez at the University of Montreal Hospital Research Centre (CRCHUM) sheds light on how the blood-brain-barrier (BBB) works to prevent the incursion of the immune system into the brain. Continue reading

Researchers from Université Laval affiliated CHUQ discover a new therapeutic target for Lou Gehrig’s disease

Jean-Pierre Julien

November 14, 2011. – A research team from Université Laval, led by Jean-Pierre Julien, has taken a new step in understanding the cellular mechanisms involved in Lou Gehrig’s disease, also known as amyotrophic lateral sclerosis (ALS). This disease is characterized by degeneration of neurons that control muscle activity. Continue reading